Pioglitazone Hydrochloride
- Product NDC
- 50090-5582
- 11-digit product format
- 500905582
- Labeler code
- 50090
- Product ID
- 50090-5582_7ab290ed-2153-4768-b1a1-43242e158901
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076798
- Marketing category
- ANDA
- Marketing start
- 2020-10-28
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5582 | PIOGLITAZONE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 6 | Legacy NDC | 20230208_5ae36a91-1392-4aed-8e71-0cfbb6ff860a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5582-0 | 50090558200 | 30 TABLET in 1 BOTTLE (50090-5582-0) | 30 tablet | 2021-07-07 | 0000-00-00 | No | No | Current |
| 50090-5582-1 | 50090558201 | 90 TABLET in 1 BOTTLE (50090-5582-1) | 90 tablet | 2021-07-07 | 0000-00-00 | No | No | Current |